Brief: Gritstone Bio Presents Advances In Neoantigen Prediction And Cancer Vaccine Immunogenicity
17/04/2023 12:13
April 17 (Reuters) - Gritstone bio Inc GRTS.O :
* GRITSTONE BIO PRESENTS ADVANCES IN NEOANTIGEN PREDICTION
AND
CANCER VACCINE IMMUNOGENICITY AT THE 2023 AACR ANNUAL MEETING
Source text for Eikon: ID:nGNXP6mPP
Further company coverage: GRTS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gritstone bio
See all newsBrief: Gritstone Bio Inc On Dec 31 2024, Vassiliki “Celia” Economides Became Interim CEO As Well As CFO Of Co
Brief: Gritstone Bio Announces Strengthening Of Maturing Phase 2 PFS Data for GRANITE Study And Provides Business Update
U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma
U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma
U.S. STOCKS ON THE MOVE-PPG Industries, Travelers, ShiftPixy